|
Related Party Transactions (Details Textual) (USD $)
|
1 Months Ended | 12 Months Ended | |
|---|---|---|---|
|
Feb. 29, 2012
|
Jun. 30, 2013
|
Jun. 30, 2012
|
|
| Accounts Payable, Related Parties, Current | $ 93,000 | $ 2,524,000 | |
| Research and Development Expense | 3,431,000 | 4,981,000 | |
| General and Administrative Expense | 4,243,000 | 5,623,000 | |
| Interest Expense | 90,000 | 63,000 | |
|
Board Member Consulting [Member]
|
|||
| General and Administrative Expense | 15,000 | 75,000 | |
| Share-based Goods and Nonemployee Services Transaction, Shares Approved for Issuance | 60,000 | ||
| Annual Fee Paid to Board of Director | 10,000 | 10,000 | |
| Share-based Goods and Nonemployee Services Transaction Exercise Price | $ 0.93 | ||
| Share-based Goods and Nonemployee Services Transaction Service Period | 6 months | ||
|
Vendor [Member]
|
|||
| Research and Development Expense | 424,000 | 225,000 | |
|
Fraunhofer Shared Employee [Member]
|
|||
| Research and Development Expense | 3,991,000 | ||
| General and Administrative Expense | 200,000 | ||
| Interest Expense | $ 100,000 | ||
| X | ||||||||||
|
- Definition
Amount of annual fee paid to board of director. No definition available.
|
| X | ||||||||||
|
- Definition
The weighted average of per share prices paid for shares purchased on the open market for issuance to Non-employee services transaction. No definition available.
|
| X | ||||||||||
|
- Definition
The vesting period of the non-employee stock options. No definition available.
|
| X | ||||||||||
|
- Definition
Amount for accounts payable to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of the cost of borrowed funds accounted for as interest expense. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The maximum number of shares (or other type of equity) that have been approved for issuance in the equity-based payment transaction. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|